CREB1 and obesity due to melanocortin 4 receptor deficiency: These metabolic benefits of carvedilol might be attributed to its ability to block the adrenergic overactivation in obesity since increased p-Creb levels in livers and muscles of the HFD-fed mice were totally blunted by carvedilol treatment.